The world needs to urgently prepare for a potential avian flu pandemic.
Scientists Are Testing mRNA Bird Flu Vaccines
Development of mRNA vaccines for bird flu in cows to protect humans. Plans for mRNA flu vaccines alongside traditional egg-based methods for potential pandemics.
The pathogens that could spark the next pandemic
The WHO updated the list of priority pathogens to over 30, aiding in allocating resources for treatment and vaccine development.
Has the next pandemic already started?
The world needs to urgently prepare for a potential avian flu pandemic.
Scientists Are Testing mRNA Bird Flu Vaccines
Development of mRNA vaccines for bird flu in cows to protect humans. Plans for mRNA flu vaccines alongside traditional egg-based methods for potential pandemics.
The pathogens that could spark the next pandemic
The WHO updated the list of priority pathogens to over 30, aiding in allocating resources for treatment and vaccine development.
Covid-19 Is Currently Widespread in Wildlife. Should We Be Worried?
The virus SARS-CoV-2 is extensively spreading through various animal species, potentially leading to further unpredictable mutations and challenges in vaccine development.
Covid immune response study could explain why some escape infection
Specialized immune cells in the nose can effectively combat Covid at the early stage, preventing full infection.
Genes related to flagging virus presence play a crucial role in immune responses and potential vaccine development.
Chinese lab had COVID-19 mapped two weeks before global outbreak: documents
A Chinese researcher uploaded the sequence of COVID-19's structure to a US database on Dec. 28, 2019, two weeks before Beijing officially released details of the virus.
The researcher's work was nearly identical to what Beijing eventually presented to the World Health Organization on Jan. 11, 2020.
The extra two weeks could have been pivotal for the global response to the pandemic and the development of COVID-19 vaccines.
Covid-19 Is Currently Widespread in Wildlife. Should We Be Worried?
The virus SARS-CoV-2 is extensively spreading through various animal species, potentially leading to further unpredictable mutations and challenges in vaccine development.
Covid immune response study could explain why some escape infection
Specialized immune cells in the nose can effectively combat Covid at the early stage, preventing full infection.
Genes related to flagging virus presence play a crucial role in immune responses and potential vaccine development.
Chinese lab had COVID-19 mapped two weeks before global outbreak: documents
A Chinese researcher uploaded the sequence of COVID-19's structure to a US database on Dec. 28, 2019, two weeks before Beijing officially released details of the virus.
The researcher's work was nearly identical to what Beijing eventually presented to the World Health Organization on Jan. 11, 2020.
The extra two weeks could have been pivotal for the global response to the pandemic and the development of COVID-19 vaccines.
The FDA may soon authorize a spring round of COVID-19 boosters for some people
Shana Alesi administers a COVID-19 booster vaccine to Marine Corps veteran Bill Fatz at the Edward Hines Jr. VA Hospital in Hines, Ill., in 2021.A new round of boosters could become available for some people this spring.Scott Olson/Getty Images Katen Moore has already gotten every COVID-19 vaccination available the two original shots, two boosters with one of the first vaccines and a jab with one of the new vaccines updated to target omicron.
Opinion | Cheer Up! The World Is Better Off Than You Think.
Enough with the doom and gloom!Our planet may be in better shape than you think.Human beings have a cognitive bias toward bad news (keeping us alert and alive), and we journalists reflect that: We report on planes that crash, not planes that land.We highlight disasters, setbacks, threats and deaths, so 2022 has kept us busy.
Ebola vaccines produced lasting antibodies during trial: Studies
Studies in West Africa said that the vaccines developed by Johnson & Johnson and Merck & Co appear to be safe in children and adults.Ebola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies conducted in West Africa.
Moderna's mRNA Skin Cancer Vaccine Shows Early Promise in a New Study
Coming off the success of its mRNA vaccine for COVID-19, Moderna announced on Dec. 13 that it achieved encouraging results when it turned its vaccine technology against cancer.The company reported in a release that among 157 people with stage 3 or stage 4 melanoma, a personalized cancer vaccine that Moderna developed with Merckcreated using mRNA genetic material from each patient's respective tumorsreduced the risk of recurrence or death by 44% compared to standard care.
The FDA may soon authorize a spring round of COVID-19 boosters for some people
Shana Alesi administers a COVID-19 booster vaccine to Marine Corps veteran Bill Fatz at the Edward Hines Jr. VA Hospital in Hines, Ill., in 2021.A new round of boosters could become available for some people this spring.Scott Olson/Getty Images Katen Moore has already gotten every COVID-19 vaccination available the two original shots, two boosters with one of the first vaccines and a jab with one of the new vaccines updated to target omicron.
Opinion | Cheer Up! The World Is Better Off Than You Think.
Enough with the doom and gloom!Our planet may be in better shape than you think.Human beings have a cognitive bias toward bad news (keeping us alert and alive), and we journalists reflect that: We report on planes that crash, not planes that land.We highlight disasters, setbacks, threats and deaths, so 2022 has kept us busy.
Ebola vaccines produced lasting antibodies during trial: Studies
Studies in West Africa said that the vaccines developed by Johnson & Johnson and Merck & Co appear to be safe in children and adults.Ebola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies conducted in West Africa.
Moderna's mRNA Skin Cancer Vaccine Shows Early Promise in a New Study
Coming off the success of its mRNA vaccine for COVID-19, Moderna announced on Dec. 13 that it achieved encouraging results when it turned its vaccine technology against cancer.The company reported in a release that among 157 people with stage 3 or stage 4 melanoma, a personalized cancer vaccine that Moderna developed with Merckcreated using mRNA genetic material from each patient's respective tumorsreduced the risk of recurrence or death by 44% compared to standard care.